As of 2025-09-18, the Relative Valuation of Cogent Biosciences Inc (COGT) is (40.26) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.54 USD, the upside of Cogent Biosciences Inc based on Relative Valuation is -421.1%.
The range of the Relative Valuation is (34.16) - (41.73) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 20.5x | 18.0x |
| Forward P/E multiples | 16.8x - 26.4x | 21.6x |
| Fair Price | (34.16) - (41.73) | (40.26) |
| Upside | -372.4% - -432.7% | -421.1% |
| Date | P/E |
| 2025-09-15 | -6.10 |
| 2025-09-12 | -6.23 |
| 2025-09-11 | -6.30 |
| 2025-09-10 | -6.27 |
| 2025-09-09 | -6.30 |
| 2025-09-08 | -6.24 |
| 2025-09-05 | -6.42 |
| 2025-09-04 | -6.36 |
| 2025-09-03 | -6.43 |
| 2025-09-02 | -5.90 |
| 2025-08-29 | -5.94 |
| 2025-08-28 | -5.94 |
| 2025-08-27 | -6.08 |
| 2025-08-26 | -6.01 |
| 2025-08-25 | -5.80 |
| 2025-08-22 | -5.96 |
| 2025-08-21 | -5.79 |
| 2025-08-20 | -5.83 |
| 2025-08-19 | -5.78 |
| 2025-08-18 | -5.96 |
| 2025-08-15 | -5.85 |
| 2025-08-14 | -5.76 |
| 2025-08-13 | -5.89 |
| 2025-08-12 | -5.68 |
| 2025-08-11 | -5.38 |
| 2025-08-08 | -5.39 |
| 2025-08-07 | -5.34 |
| 2025-08-06 | -5.39 |
| 2025-08-05 | -5.59 |
| 2025-08-04 | -5.93 |
| 2025-08-01 | -5.61 |
| 2025-07-31 | -5.62 |
| 2025-07-30 | -5.67 |
| 2025-07-29 | -5.82 |
| 2025-07-28 | -5.95 |
| 2025-07-25 | -5.94 |
| 2025-07-24 | -5.99 |
| 2025-07-23 | -6.08 |
| 2025-07-22 | -6.12 |
| 2025-07-21 | -6.05 |
| 2025-07-18 | -6.14 |
| 2025-07-17 | -6.00 |
| 2025-07-16 | -5.83 |
| 2025-07-15 | -5.66 |
| 2025-07-14 | -5.45 |
| 2025-07-11 | -5.40 |
| 2025-07-10 | -5.34 |
| 2025-07-09 | -5.11 |
| 2025-07-08 | -4.81 |
| 2025-07-07 | -4.60 |